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1. Introduction
Food safety is threatened by numerous pathogens and toxins, 
including mycotoxins, which are associated to a variety of 
acute and chronic foodborne diseases. From an economic 
and public health standpoint, the foodborne mycotoxins 
that are considered as being relevant are aflatoxins (AFs), 
fumonisins (FBs), certain trichothecene mycotoxins 
(including deoxynivalenol (DON) and T-2 and HT-2 toxins), 
ochratoxin A (OTA), patulin (PAT) and zearalenone (ZEA). 
Briefly, AFs are strong hepatocarcinogens and have also 
been implicated in child growth impairment and acute 
toxicoses; FBs have been associated with oesophageal cancer 
and neural tube defects; DON and other trichothecenes, 
display immunotoxic effects and cause gastroenteritis; OTA 
has been associated to nephrotoxicity and renal cancer; 
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Abstract
Most fungi are able to produce several mycotoxins simultaneously and, consequently, to contaminate a wide variety 
of foodstuffs. Therefore, the risk of human co-exposure to multiple mycotoxins is real, raising a growing concern 
about their potential impact on human health. Besides, government and industry regulations are usually based 
on individual toxicities, and do not take into account the complex dynamics associated with interactions between 
co-occurring groups of mycotoxins. The present work assembles, for the first time, the challenges posed by the 
likelihood of human co-exposure to these toxins and the possibility of interactive effects occurring after absorption, 
towards knowledge generation to support a more accurate human risk assessment. Regarding hazard assessment, a 
physiologically-based framework is proposed in order to infer the health effects from exposure to multiple mycotoxins 
in food, including knowledge on the bioaccessibility, toxicokinetics and toxicodynamics of single and combined 
toxins. The prioritisation of the most relevant mixtures to be tested under experimental conditions that attempt 
to mimic human exposure and the use of adequate mathematical approaches to evaluate interactions, particularly 
concerning the combined genotoxicity, were identified as the main challenges for hazard assessment. Regarding 
exposure assessment, the need of harmonised food consumption data, availability of multianalyte methods for 
mycotoxin quantification, management of left-censored data, use of probabilistic models and multibiomarker 
approaches are highlighted, in order to develop a more precise and realistic exposure assessment. To conclude, 
further studies on hazard and exposure assessment of multiple mycotoxins, using harmonised methodologies, are 
crucial towards an improvement of data quality and a more reliable and robust risk characterisation, which is central 
for risk management and, consequently, to prevent mycotoxins-associated adverse effects. A deep understanding 
of the nature of interactions between multiple mycotoxins will contribute to draw real conclusions on the health 
impact of human exposure to mycotoxin mixtures.
Keywords: mycotoxins mixtures, human risk assessment, combined toxicity, food safety, human health
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PAT induces gastrointestinal effects, as inflammation and 
ulcers; and ZEA affects the reproductive function (CAST, 
2003; WHO, 2011; Wu et al., 2014). These mycotoxins are 
able to naturally contaminate commodities at toxicologically 
relevant concentrations and are the focus of legislation and 
regulations in the European Union and beyond (Clarke et 
al., 2014; Wu et al., 2014). Maximum levels (MLs) are set in 
EU legislation to control these mycotoxin levels in food and 
feed (EC, 2002, 2006). Besides the parent forms, potential 
health effects of modified mycotoxins are also relevant 
due to their possibility to be hydrolysed to the more toxic 
parent mycotoxins and thus lead to an increased health 
risk (Berthiller et al., 2013; Stoev, 2015).
All over the world, recent surveys highlight the fact that 
humans are more frequently exposed to multiple than 
to single mycotoxins (De Ruyck et al., 2015; Grenier and 
Oswald, 2011; Solfrizzo et al., 2014; Stoev, 2015) given 
the natural co-occurrence of mycotoxins in food and 
the globalisation of food markets (McKean et al., 2006). 
Furthermore, climate changes towards an increase of 
temperature and humidity in certain European regions 
are expected to favour the growth of contaminating fungi, 
thereby increasing the likelihood of food commodities 
contamination with mycotoxins (Paterson and Lima, 
2010). As a consequence, there has been an increasing 
concern about the health hazard from exposure to multiple 
mycotoxins (mycotoxin mixtures) in human and animals. 
Several studies have reported on the combined effects of 
mycotoxins (Alassane-Kpembi et al. 2016; Corcuera et al., 
2011; Klarić et al., 2013; Speijers and Speijers, 2004; Tavares 
et al., 2013, 2015) but the nature of the observed effect or 
the relative potencies of each mycotoxin in the mixture are 
not fully understood yet (Wan et al., 2013), thus limiting 
the actual health risk assessment to their single effects.
Human risk assessment is based on a 4-step process, namely 
(1) hazard identification and (2) characterisation (both also 
considered as hazard assessment) examining if, and the 
conditions by which, a certain mycotoxin has the potential 
to cause a particular adverse health effect or disease and the 
numerical relationship between the level of dietary exposure 
(dose) and the associated adverse effect (response); (3) 
exposure assessment, estimating the frequency, intensity, 
and duration of ingestion of a mycotoxin; and (4) risk 
characterisation, integrating the results of the exposure 
assessment with those of hazard characterisation to estimate 
the degree of concern (FAO/WHO, 1997).
Historically, the health risk from human exposure to 
chemical contaminants has been evaluated on the basis 
of single-chemical and single-exposure pathway scenarios. 
In general, exposures to a chemical through the food 
were assessed independently, and no concerted effort 
had been made to evaluate potential multiple exposures 
simultaneously. However, in the last years a tiered approach 
has been proposed by the World Health Organization 
(WHO) and by the European Food Safety Authority 
(EFSA) in order to assess the risk of multiple chemicals, 
including contaminants (EFSA, 2013; Meek et al., 2011). 
This hierarchical approach involves integrated and iterative 
considerations of exposure and hazard at all phases, with 
each tier being more refined (i.e. less conservative and 
uncertain) than the previous one, but more laborious and 
intensive. The framework comprises a tiered approach 
for exposure assessment, hazard assessment and risk 
characterisation and requires at the higher tiers increasing 
knowledge about the group of chemicals under assessment. 
Briefly, the tiers can range from tier 0 (default values, data 
poor situation) to tier 3 (full probabilistic models) (EFSA, 
2013; Meek et al., 2011).
Considering that risk assessment is intimately related to 
the establishment of regulatory guidelines, once the risk 
assessment is completed, an effort to reduce or manage the 
risk should be followed to protect public health (Renwick et 
al., 2003). The food safety legislation through mycotoxins 
risk assessment is in place to control mycotoxins in food 
and includes single and sum of maximum levels for some 
mycotoxins in foodstuffs (EC, 2006). Some approaches 
are now being reported for the first time in the literature 
concerning the risk assessment of co-occurring mycotoxins 
in foodstuffs (Assunção et al., 2015; De Boevre et al., 
2013; Han et al., 2014) but far more research is required 
concerning the nature of interactions between multiple 
mycotoxins until real conclusions could be drawn 
concerning the health impact of mycotoxin mixtures.
Following the increasing interest of risk assessors, regulators 
and scientific community on the risk assessment of multiple 
mycotoxins in food, recent international meetings and 
research projects had pointed out the urgent need to 
address and discuss issues such as the co-occurrence of 
mycotoxins, their combined toxicity and cumulative risk 
assessment, namely: the ‘International Conference on Food 
Contaminants: challenges in chemical mixtures’, 2015 
(ICFC2015) (http://hdl.handle.net/10400.18/3214); a course 
and a symposium within the 51st Congress of the European 
Societies of Toxicology, 2015 (http://www.eurotox2015.
com); the Portuguese project entitled ‘MycoMix, Exploring 
the toxic effects of mixtures of mycotoxins in infant food 
and potential health impact’ (Alvito et al., 2015); and the 
EU research project entitled ‘EuroMix, A tiered strategy for 
risk assessment of mixtures of multiple chemicals’ (https://
www.euromixproject.eu/).
Risk assessment of combined human exposure to multiple 
mycotoxins poses several challenges to scientists, risk 
assessors and risk managers and open new avenues for 
research. This work aims to give a holistic overview of 
the main challenges and perspectives concerning the risk 
assessment of multiple mycotoxins in food, as a scientific 
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evaluation process. For this purpose, the following sections 
include a general overview and report recent advances 
in mycotoxin research and main challenges for each risk 
assessment step.
2. Hazard assessment of multiple mycotoxins
An overview of hazard assessment of single and multiple 
mycotoxins
Information on the hazard assessment of a chemical to 
which humans are exposed to is a determinant step within 
the human health risk assessment. Particular attention has 
been dedicated in last years to the occurrence of multiple 
chemicals in food leading to a change in the paradigm 
of the hazard assessment. The urgent need for a deep 
understanding of the potential effects of chemicals in 
mixture gave rise to the concept of combined toxicity which 
is defined as the ‘response of a biological system to several 
chemicals, either after simultaneous or sequential exposure’ 
(EFSA, 2013; Loewe and Muischnek, 1926). Combined 
toxicity can take three possible forms: concentration 
addition (CA), independent action (IA) or interaction 
(Loewe and Muischnek, 1926). According to the CA model, 
the joint action of multiple chemicals is the summation of 
individual toxicities, assuming the same Mode of Action 
(MoA) and/or at the same target cell, tissue or organ. In 
the IA model, the combined effects are estimated assuming 
that chemicals act independently by dissimilar MoA or at 
different target cells, tissues or organs and considers that 
the probability of toxicity from exposure to one chemical is 
independent from the probability of toxicity from exposure 
to another chemical in the mixture (Bliss, 1939; Jonker et al., 
2004; Meek et al., 2011). These two reference models have 
found successful application to toxicological assessments 
of mixtures of similarly acting and dissimilarly acting 
compounds, both in ecotoxicology studies using a range 
of species (Backhaus et al., 2004; Faust et al., 2003; Loureiro 
et al., 2010) and in human toxicity studies using cell lines or 
animal models (Mueller et al., 2013; Tavares et al., 2013). 
Deviation from these models include synergism (mixture 
effect greater than additive), antagonism (mixture effect less 
than additive) and more subtle interactions that depend on 
the actual doses of the mixture components (e.g. synergism 
at low doses and antagonism at higher doses) or on the 
ratio of doses between the compounds in the mixture (e.g. 
the extent of the synergism or the antagonism depends on 
the relative contribution of each compound in the mixture) 
(Jonker et al., 2004, 2005). Because MoA of chemicals in 
mixtures is often unknown or incompletely understood, a 
frequent option has been the application of both models of 
CA and IA for actual effect prediction, rather than making a 
theoretically based choice. However, from a practical point 
of view the application of a single model for all situations is 
desirable and, being the CA the most conservative model, 
EFSA recommended its use within the risk assessment of 
food contaminants that includes mycotoxins (EFSA, 2013).
Particular attention must be dedicated to carcinogens in 
hazard assessment, including mycotoxins and other food 
contaminants (Jeffrey and Williams, 2005). Genotoxicity, 
i.e. the capacity of exerting a damaging effect on the cell’s 
genetic material (DNA, RNA, chromosomes) affecting 
its integrity and/or function is a major mechanism that 
contributes to the carcinogenic process. Considering 
that genetic events, such as gene mutations, structural or 
numerical chromosomal aberrations and recombination 
are closely related with carcinogenesis, genotoxic effects 
can be characterised in a faster, easier, and inexpensive 
way using standard in vitro and in vivo genotoxicity 
assays, instead of performing long-term carcinogenesis 
assays in animals (Dearfield and Moore, 2005; Louro et 
al., 2015). However, chemicals acting through a non-
genotoxic mechanism, including induction of epigenetic 
events and mitogenesis, can be equally relevant to the 
carcinogenic process. Therefore, besides genotoxicity 
testing, mechanistic studies are also needed to clarify the 
MoA of carcinogenic agents. In this respect, it is generally 
assumed that a threshold of exposure may be determined 
for non-genotoxic carcinogens, below which no biologically 
significant effect will be induced (Dybing et al., 2008). In 
contrast, from a conservative and health protection point 
of view, it has been assumed that genotoxic carcinogens 
act by a non-threshold mechanism, giving rise to linear 
dose-response curves. The decision on whether or not 
a chemical is genotoxic is thus of primary importance to 
select between a non-threshold or threshold risk assessment 
approach in the step of hazard identification.
A framework, similar to the one suggested by Spurgeon 
et al. (2010) to understand the effects of environmental 
chemical mixtures, may be proposed to investigate the 
combined toxicity of multiple mycotoxins in food and 
their potential impact on human health. The framework 
incorporates the concepts of external exposure or 
‘bioavailability’ of the mixture in the environment together 
with its exposure in the target species associated with 
accumulation through toxicokinetics to the expression 
of toxicity as mediated via receptor interactions within 
toxicodynamics. A similar framework could be suggested 
to investigate the health effects of multiple mycotoxins in 
food reflecting physiological conditions occurring from 
ingestion of mycotoxins to their effects on target cells, 
tissues or organs and should include three sequential 
main concepts: (1) bioaccessibility, release of mycotoxins 
from its matrix into digestive juice in the gastrointestinal 
tract (Versantvoort et al., 2005); (2) toxicokinetics; and (3) 
toxicodynamics, taking into account interactions between 
mycotoxins and/or any active metabolites and the target 
cells/tissues/organs.
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A physiologically-based framework for hazard 
assessment of mycotoxins
In human risk assessment, ingestion of food is considered a 
major route of exposure to mycotoxins. Oral bioavailability, 
defined as the fraction of an orally ingested mycotoxin 
that reaches the systemic circulation and is distributed 
throughout the body to exert its toxic effects, can be seen as 
the resultant of three processes: (1) release of the mycotoxin 
from its matrix into digestive juice in the gastrointestinal 
tract (bioaccessibility); (2) transport of the mycotoxin across 
the intestinal epithelium into the vena Portae (intestinal 
transport); and (3) biotransformation of the mycotoxin 
in the liver (and intestine) (metabolism) (González-Arias 
et al., 2013; Versantvoort et al., 2005). The concept of 
bioaccessibility of mycotoxins has become important in 
the risk assessment domain considering that the amount of 
mycotoxin consumed via food (external dose) does not always 
reflect the amount available to the body (internal dose) to 
produce its toxic effects on target cells, tissues or organs 
(González-Arias et al., 2013; Versantvoort et al., 2005).
To determine the bioaccessibility, several models of different 
complexities have been proposed to simulate food digestion. 
Simulated digestion methods typically include the oral, 
gastric and small intestinal phases, and, occasionally, large 
intestinal fermentation. The majority of models reported 
in literature are the static ones (Gil-Izquierdo et al., 2002; 
Hur et al., 2011; Versantvoort et al., 2005). However, more 
sophisticated dynamic in vitro models are also available and 
although more realistic, they are complex and expensive 
(Avantaggiato et al., 2004; González-Arias et al., 2013). 
A recent review (González-Arias et al., 2013) on the 
bioaccessibility of single mycotoxins reported, in general, 
high bioaccessibility values for AFs and FBs, (70-100%), 
intermediate values for PAT and DON (30-70%) and lower 
values for ZEA. The bioaccessibility of OTA has proven 
to be very variable, including values near 100%, but also 
below 30%. Until now, few data on the bioaccessibility of 
co-occurring mycotoxins are available, namely for AFs 
(Kabak and Ozbey, 2012), AFB1 and OTA (Kabak et al., 
2009; Raiola et al., 2012; Versantvoort et al., 2005), enniatin 
(Meca et al., 2012; Prosperini et al., 2013), trichothecenes 
T-2 and HT-2 toxin (Monaci et al., 2015). A very recent 
preliminary study evaluated the possible interactions that 
could happen when PAT and OTA co-occur in cereal-based 
baby foods (Assunção et al., 2016).
The in vitro digestion models could also be used in 
combination with intestinal models (e.g. Caco-2 cells) to 
address further mechanistic questions, such as intestinal 
transport, contributing to an accurate mycotoxin risk 
assessment, offering a more complete picture of what 
happens during digestion in the intestinal tract (De Nijs et al., 
2012; Meca et al., 2012; Prosperini et al., 2012; Versantvoort 
et al., 2005).
Regarding toxicokinetics, absorption occurs mainly through 
ingestion for chemicals in food and a central issue relates 
to the passage across the gut wall and entering into the 
blood circulation, although for some chemicals, uptake 
is restricted to the epithelium of the gastrointestinal tract 
(FAO/WHO, 2009). The sites of passive or active uptake 
across body barriers, depending on the chemical nature 
of the toxins, are potential points of interactions because 
one toxin might affect the efficiency of the uptake or 
elimination of other components of the mixture. In cases 
where toxins enter or are eliminated through selective 
transporters, competition between mycotoxins at relevant 
surface transporters can take place and can result in changes 
in uptake, bioaccessibility and toxicity, depending on the 
relative affinity of each toxin for the transporter.
Once (multiple) chemicals have entered the systemic 
circulation they can interact, inhibit or induce a range 
of metabolic pathways including phase I enzymes (e.g. 
cytochromes P450, (CYPs)), phase II enzymes (e.g. 
glutathione-S transferases) and antioxidant defence 
enzymes (e.g. superoxide dismutase or catalase) (Streetman 
et al., 2000). These systems provide a network of responses 
directed mainly to the detoxification of chemicals but in 
some cases lead the production of toxic metabolites. This 
is the case of AFB1 biotransformation by CYP3A4 and 
1A2 that results in the formation of an exo-epoxide and 
AFQ1, whilst CYP1A2 can lead to the formation of some 
exo-epoxide but also a high proportion of endo-epoxide 
and AFM1 (Dohnal et al., 2014). The exo-epoxide binds to 
DNA and forms a pre-mutagenic lesion that mediates AFB1 
mutagenicity and carcinogenicity (Bedard and Massey, 2006; 
Wild and Turner, 2002). It is plausible that interactive effects 
may occur when two or more mycotoxins are metabolised 
through the same pathway, so that one mycotoxin might 
substantially impact on the detoxification of the other ones. 
This may be mediated either by a competitive inhibition 
or by an over-induction of the metabolic system and a 
faster biotransformation of the mycotoxins. In the work 
by Corcuera et al. (2011) antagonistic genotoxic effects 
of OTA and AFB1 combinations were observed in liver-
derived HepG2 cells, concomitantly with an increase of 
intracellular reactive oxygen species (ROS). The authors 
hypothesised that competition between both toxins to the 
same CYP enzymes could have resulted in a lower amount 
of the mutagenic AFB1 exo-epoxide molecules and thus in a 
lower level of DNA damage. Concerning interactions at the 
level of phase II metabolism, Tavares et al. (2013) proposed 
that the co-existence of OTA and AFM1 in Caco-2 cells 
might have resulted in a competition for the glutathione 
molecules, decreasing the level of ROS produced by OTA 
and hence leading to an antagonistic cytotoxic effect.
A further source of mixture interactions relates to its 
toxicodynamics, i.e. at the level of the dynamic contact 
of a toxicant with its biological target, possibly impacting 
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on its biological effects at target cells/tissues/organs. For 
mycotoxins with a similar MoA, the assumption within 
the CA model is that both toxins are present at the target 
site, and each one is able to bind freely with no stimulatory 
or competitive influences. In mammalian systems, the 
toxicodynamic consequences of receptor-binding have 
been associated with a variety of effects, ranging from 
neurotoxicity, renal toxicity and cardiovascular toxicity 
(Dorne et al., 2007). Carefully designed experiments and 
informatics approaches can be used to investigate the 
mechanistic basis of mixture effects.
Evaluation of combined effects of multiple mycotoxins
The number of studies addressing the combined effects 
of mycotoxins using in vitro and in vivo models and 
several endpoints (e.g. cytotoxicity, immunotoxicity and 
genotoxicity) has been steadily increasing in the last decade 
giving rise to a set of data that might greatly contribute to 
hazard assessment of multiple mycotoxins. Šegvić Klarić 
(2012) and, more recently, Alassane-Kpembi et al. (2016) 
have comprehensively reviewed combined toxicity studies 
involving regulated groups of mycotoxins, particularly, 
OTA, AFs, Fusarium toxins, trichothecenes and emerging 
mycotoxins, e.g. beauvericin and enniatins. Cytotoxicity 
assays, using a diversity of cell lines have been widely 
used because they are fast and economic assays that may 
help predicting the in vivo toxicity of combinations of 
mycotoxins co-occurring in food (Creppy et al., 2004; 
Tiemann and Dänicke, 2007), with the advantage of 
allowing the reduction of the number of animals under 
experimentation, in compliance with the European Union 
recommendations (EC, 2010). Combinations involving AFB1 
or OTA are among the most frequently assessed, due to 
concerns related to their recurrent occurrence in several 
mixtures and their severe chronic adverse effects that can 
be even amplified if a synergistic effect is identified.
The potential of mycotoxins to elicit a cytotoxic response is 
transversal to many recent works, but some controversy still 
remains about the pattern that better describes mycotoxins 
combined effect. Table 1 compiles data from the joint effects 
of AFB1 or OTA as components of several mixtures assessed 
in vitro and, more rarely, in vivo. For instance, combinations 
of OTA, AFB1 and FB1 in three different mammalian cell 
lines showed synergistic cytotoxic effects with regard to 
mitochondrial integrity although binary mixtures of the 
same mycotoxins followed the additivity pattern (Clarke et 
al., 2014). Noteworthy, no interactive effect was observed 
for mycotoxin mixtures tested at the EU regulatory limits, 
which highlights the relevance of using an appropriate dose-
range in the in vitro studies. For binary mixtures involving 
OTA, additive toxic effects were observed for combinations 
with AFB1 in kidney cells (Golli-Bennour et al., 2010) and 
in hepatoma-derived cells (Corcuera et al., 2011), whereas 
synergistic effects were reported in rat brain glioma, Caco-
2 and Vero cells (Creppy et al., 2004); antagonism was 
described for the combined toxicity of OTA and AFM1 in 
Caco-2 cells (Tavares et al., 2013). In addition, synergistic 
effects between OTA and CIT were identified in renal cells 
in vitro (Bouslimi et al., 2008; Heussner et al., 2006) and in 
vivo (Pfohl-Leszkowicz et al., 2008). Recently, the effect of 
the ternary mixture of OTA, citrinin and sterigmatocystin 
was explored in a human hepatocellular cancer cell line 
(Hep3B), showing a synergistic effect at low toxin doses that 
shifted to antagonism at higher concentrations (Αnninou 
et al., 2014). A similar dose-dependent interactive effect 
was found for the joint effects of OTA and FB1 in human 
hepatoma and human renal cells (Tavares et al., 2015). Apart 
from mixtures involving OTA or AFB1, the combined effects 
of a number of other mycotoxins combinations have been 
also addressed in the last years, including Fusarium and 
Alternaria toxins (Vejdovszky et al., 2016), DON, NIV and 
their acetylated derivatives (Alassane-Kpembi et al., 2015) 
or BEA, DON and T2-toxin (Ruiz et al., 2011), to name only 
some studies. Factors related to the experimental design, 
including the concentration range of the single toxins 
and relative concentration of each toxin in the mixture or 
the metabolic capacity of the target cell are central to the 
combined final effect and have to be carefully controlled.
Another important aspect relates to the approaches that 
have been applied to quantitatively measure the dose-effect 
relationships of single mycotoxins and its combinations 
and to ascertain putative interactive effects. Among them, 
the usefulness of the combination index (CI)-isobologram 
equation by Chou (2006) and Chou and Talalay (1984), 
which is based on the median-effect principle (mass-action 
law) that demonstrates that there is an univocal relationship 
between dose and effect, independently of the number of 
substrates or products and of the mechanism of action or 
inhibition (Alassane-Kpembi et al., 2013; Bernhoft et al., 
2004; Ruiz et al., 2011) (Table 1). This method involved 
plotting the dose-effect curves for each compound and 
their combinations in multiple diluted concentrations and 
is based on the assumption that when two compounds 
are combined and subjected to several dilutions, the 
combined mixture of the two compounds behaves as 
the third compound for the dose-effect relationship. The 
CI indicates not only the type of interaction (additivity, 
synergism or antagonism) but also the magnitude of the 
interaction found. In addition, the conceptual models of 
CA and IA incorporating also a set of deviation functions 
within a nested framework (Jonker et al., 2004, 2005) have 
been effectively applied to the analysis of cytotoxic effects 
of mycotoxins mixtures (Tavares et al., 2013; Table 1).
Several prerequisites are required to allow the application 
of these models, implicating a careful experimental design 
that will depend on the number of chemicals in the mixture 
and the degree of detail needed concerning the dose-effect 
relationship for single and combined toxicity; the single 
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compounds in the mixture should be tested at a constant 
dose ratio, using a full factorial design. This approach was 
employed by Tavares et al. (2013) to assess the combined 
effect of OTA and AFM1 in an intestine cell line, following 
determination of the inhibitory concentration at 50% (IC50) 
of the single toxins. Both CA and IA models were applied 
to derive potential interactions at concentrations below 
the individual IC50. Whereas the well-known CA model 
assumes that both toxins have a similar MoA, the IA model 
assesses the probability of toxicity from exposure to one 
mycotoxin being independent from the toxicity of the other 
toxin in the mixture (Jonker et al., 2004, 2005). A fairly 
good agreement was obtained for both models, in that 
antagonism was found after the CA model fit, while a dose 
level deviation was observed after IA modelling, where 
antagonism was observed at low dose levels and synergism 
at high dose levels. However, when dealing with a mixture 
of several chemicals, where the number of experimental 
groups increases exponentially, fractionated factorial 
designs can be used to identify interactions in a manageable 
way (Groten et al., 2004). Another possibility is to apply 
a tiered approach as suggested by Tajima et al. (2002) for 
Fusarium mycotoxins, starting from the study of the whole 
mixture effect, followed by a screening of interactions using 
a fractionated factorial design and, finally the confirmation 
of interaction through a full factorial design.
In spite of the number of studies addressing the cytotoxicity 
of multiple toxins, genotoxicity is of a greater concern 
for most of the mycotoxins and their mixtures due to 
its association to carcinogenesis. However, the specific 
genotoxic properties of multiple mycotoxins are much 
more difficult to address comprehensively in complex 
combinatory experiments and thereby studies reporting 
combined genotoxic effects of mycotoxins are more 
limited. Interestingly, among the in vitro studies available, 
additivity or even antagonism are the predominant joint 
effects of mixtures containing AFB1 or OTA (Table 1). A 
common drawback of in vitro studies is the use of dose-
ranges that are much higher than those that have been 
found in biological fluids of exposed humans. Thus, further 
studies using realistic concentrations that follow a carefully 
planned experimental design are still needed. Moreover, 
for those mixtures showing interactive effects in in vitro 
assays, confirmatory in vivo assays should be used to better 
predict the effects on humans. For instance, the combined 
genotoxic effect of OTA and CIT was explored in a Chinese 
hamster lung cell line showing a synergism at low doses 
that changed to antagonism at higher doses (Föllmann et 
al., 2014). A synergistic effect was also observed through 
the analysis of chromosome aberrations in bone marrow 
cells from exposed mice (Bouslimi et al., 2008), confirming 
that low doses are more realistic and thus more relevant to 
predict in vivo effects. On the other hand, Corcuera et al. 
(2011) showed that the mixture of OTA and AFB1 produced 
an antagonistic DNA damaging effect, comparatively to 
each single toxin. The observed antagonism was further 
confirmed in liver and bone marrow cells of exposed rats 
using the comet and the micronucleus assays, respectively 
(Corcuera et al., 2015). These two examples suggest that 
carefully designed in vitro studies on combined genotoxic 
effects of mycotoxins may have a good predictive value 
for their in vivo joint effect, as advocated by Creppy et al. 
(2004). Nevertheless, more in vivo genotoxicity studies are 
urgently needed, using the oral route of exposure, realistic 
concentrations derived from human exposure data and 
allowing the quantification of several endpoints (e.g. DNA 
breaks, chromosome numerical and structural anomalies, 
gene mutations) to confirm the value of in vitro approaches. 
Furthermore, the application of mathematical models to 
ascertain genotoxic interactive effects, similarly to what 
has been done for combined cytotoxicity assessment, is 
highly relevant to have firm and reliable conclusions about 
genotoxic interactive effects. In this sense, Ermler et al. 
(2014) have already shown that the CA, IA and hybrid 
CA/IA models are applicable to data obtained for several 
model compounds with similar and dissimilar MoA, using 
the micronucleus assay.
Main challenges in hazard assessment of multiple 
mycotoxins
Knowledge of the real percentage of mycotoxins that 
can be absorbed in the small intestine would enable a 
more accurate risk assessment. Several factors may affect 
the bioaccessibility of single and multiple mycotoxins. 
Variability within mycotoxin bioaccessibility values depends 
on the compound, food product, contamination level and 
way of contamination (spiked or naturally contaminated) 
(Kabak et al., 2009). Additionally, the diversity of in vitro 
digestion models used to access the bioaccessibility of 
mycotoxins constitutes another important challenge. The 
individual static in vitro digestion models described in 
the literature exhibit significant variations in the in vitro 
digestion parameters as pH, mineral type, ionic strength and 
digestion time, which alter enzyme activity (González-Arias 
et al., 2013; Minekus et al., 2014). Consequently, this fact 
hampers the possibility to compare results across research-
groups and to deduce general findings. To overcome this 
difficulty, recently a standardised static in vitro digestion 
model suitable for food was developed within the COST 
action INFOGEST (https://www.cost-infogest.eu/). This 
standardised digestion method (Egger et al., 2015; Minekus 
et al., 2014) is based on the current state of knowledge 
on in vivo digestion conditions and describes a detailed 
line-by-line protocol (https://www.youtube.com/channel/
UCdc-NPx9kTDGyH_kZCgpQWg) with recommendations 
and justifications on the experimental procedures applied.
Mycotoxin absorption constitutes another challenge 
within risk assessment considering that toxins could reach 
intestine as the parent compound or as metabolites formed 
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during the digestion, and methods for their detection 
are not yet developed or currently available (González-
Arias et al., 2013).
The level of effort required for hazard assessment of the 
combined effect of multiple chemicals to humans or to the 
ecosystem is quite high and should be initially weighted 
by the magnitude of potential risks, the objective (e.g. 
priority setting or screening for additional focus or risk 
management) and scope (e.g. local and national interest) 
(Meek et al., 2011). Since testing the combined effects of 
all possible combinations of mycotoxins is not feasible in 
a reasonable timeframe, priorities for hazard assessment 
need to be set in order to put more effort into the most 
relevant mixtures. The rational for priority setting may be 
based on the frequency of its co-occurrence in food, the 
hazardous potency of the single toxins, the structure-activity 
relationship pointing to a strong probability of interactions 
or on preliminary data suggesting synergistic effects. Even 
though the available data concerning combined toxic effects 
of mycotoxins have been growing, a considerable degree 
of inconsistency is noted when comparing the outcomes 
of studies focused on similar mixtures and therefore, more 
studies are needed to allow firm conclusions. Given that 
these studies are laborious and time consuming, the future 
utilisation of simpler and faster electrochemical biosensors 
(exemplified in Gu et al., 2015) and high content analysis 
that allows the simultaneous examination of a large set of 
endpoints with high sensitivity (Clarke et al., 2015) are 
promising advances in combinatory toxicology. Studies on 
combined genotoxic effects of multiple mycotoxins are still 
scarce and more studies should be developed in order to 
go further on the risk assessment and provide information 
for risk assessors and, subsequently, for risk managers 
and regulators. In addition, exploring interactions at the 
mechanistic level remains a challenging issue and more 
studies are needed in order to clarify the biochemical, 
cellular or molecular mechanisms underlying the observed 
interactive effects. For this purpose, a systems toxicology 
approach, i.e. a toxicogenomic approach can provide 
useful information about genes expression, proteins or 
biochemical pathways within a reasonable timeframe 
from which mechanisms of toxicity can be established 
(Altenburger et al., 2012).
3. Exposure assessment of multiple mycotoxins
Overview of methods for estimating dietary exposure
Exposure assessment is a key element for quantifying risk 
and constitutes one of the four steps included in the risk 
assessment process and is usually defined as the qualitative 
and/or quantitative evaluation of the likely intake of agents 
via food as well as exposures from other sources (FAO/
WHO, 2009). Dietary exposure assessment consists of 
combining deterministically or probabilistically food 
consumption figures with occurrence of a given chemical 
substance in a number of food categories (EFSA, 2013).
Food consumption data reflect what individuals or groups 
consume in terms of solid foods, beverages, and dietary 
supplements. National food consumption surveys are 
the principal sources of information for determining real 
food consumption habits in a population of consumers. In 
addition to the general population, the risk assessments 
generally also consider the exposure of specific consumer 
groups, such as infants, children, and people following 
specific diets (e.g. vegetarians) (FAO/WHO, 2009). Food 
consumption can be estimated through food consumption 
surveys, including records/diaries, food frequency 
questionnaires and dietary recall (EFSA, 2011). The food 
records or food diaries require the report of all foods 
consumed during a specific period (usually ranging between 
24 hours to 7 days). Food frequency questionnaires consist 
of a structured listing of individual foods or food groups 
where the respondent is asked to estimate the number of 
times the food is usually consumed per day, week, month 
or year (FAO/WHO, 2009).
Considering the increasing evidence that co-contamination 
of food matrices is the rule, not the exception (Stoev, 2015), 
the proposal to quantify the simultaneous occurrence of 
multiple contaminants goes on the direction of developing 
multi-analyte methods combining a generic sample 
preparation protocol with a highly selective method 
exhibiting sufficient detection capacity, such as LC-MS 
(Malachová et al., 2014; Turner et al., 2015). EFSA suggested 
that Total Diet Studies (TDSs) provide the most accurate 
estimates of mean contamination by the chemicals in the 
food consumed by the population or collective group of 
individuals (FAO/WHO/EFSA, 2011). As TDSs consider 
total exposure from whole diets and are based on food 
contamination ‘as consumed’ rather than contamination 
from raw commodities, they are considered to ensure a 
more realistic exposure measure than exposure studies 
based on monitoring programs and surveillance data 
(Papadopoulos et al., 2015). Within the general framework 
of chemical risk assessment, a difficult step in dietary 
exposure assessment is the handling of concentration 
data reported to be below the limit of detection (LOD) 
of the analytical method. These data are known as non-
detects and the resulting distribution of occurrence values 
is left-censored. EFSA has so far mainly used substitution 
methods (EFSA, 2010). The most common approaches 
are the substitution methods that replace non-detects by 
LOD divided by 2 or producing an upper and lower bound 
by substitution of non-detects by LOD or 0, respectively 
(EFSA, 2010).
Food consumption and occurrence data are then combined 
to perform the dietary exposure assessment. A deterministic 
(point estimate) or probabilistic (stochastic) approach is 
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generally applied to perform dietary exposure assessment 
studies. The structure of the probabilistic and deterministic 
approaches is similar and is based on the same basic 
equations whereby food consumption data are combined 
with concentration data to estimate dietary exposure. 
The fundamental difference is that at least one variable is 
represented by a distribution function instead of a single 
value and the model sample from each distribution is 
a distribution of potential dietary exposures generated 
using several thousand iterations. Monte Carlo simulation 
is the technique that has been applied to a wide variety 
of modelling scenarios in probabilistic dietary exposure 
assessment (FAO/WHO, 2009; Han et al., 2014).
Worldwide exposure assessment of co-occurring 
mycotoxins in food
Human exposure is a crucial element in the risk assessment 
of mycotoxins. Table 2 summarises most recent reports on 
exposure assessment of worldwide populations to multiple 
mycotoxins in food, published in the last six years. Children 
and adults are the main population groups considered 
in these studies. Cereal based products are important 
commodities prompt to mycotoxins contamination and 
as such were an obvious target in the reported exposure 
assessment studies (wheat and maize foods, breakfast 
cereals). Nuts and dried fruits were also assessed (Cano-
Sancho et al., 2013; Cressey and Reeve, 2013; Van de Perre 
et al., 2015). AFs are the mycotoxin group most assessed 
(Assunção et al., 2015; Cano-Sancho et al., 2013; Cressey 
and Reeve, 2013; García-Moraleja et al., 2015; Signorini et 
al., 2012; Sirot et al., 2013; Van de Perre et al., 2015). Other 
evaluated mycotoxin groups include FBs, ochratoxins, PAT, 
trichothecenes and ZEA and their respective metabolites, 
enniatins, beauvericin, sterigmatocystin and Alternaria 
toxins, with a maximum of 48 mycotoxins assessed 
simultaneously (Sirot et al., 2013; Sprong et al., 2016b). 
For the exposure assessment studies, food consumption 
data were mainly obtained from national food consumption 
surveys, including different data collection methodologies, 
namely 1-day (Cressey and Reeve, 2013; Han et al., 2014), 
2-day (De Boevre et al., 2013; Sprong et al., 2016a; Van de 
Perre et al., 2015) and 3-day 24-hour recalls (Zhao et al., 
2015), 3-day food diary (Assunção et al., 2015) and 7-day 
food diary (Sirot et al., 2013), all reported in Table 2.
LC/MS-MS was the most used technique for the 
quantification of multiple mycotoxins in foodstuffs although 
LC-FD is also used in several studies for AFs quantification 
(Assunção et al., 2015; Cano-Sancho et al., 2013; Sirot 
et al., 2013). Recently, an LC-MS/MS ‘dilute and shoot’ 
method for the determination of 295 fungal and bacterial 
metabolites was optimised and validated according to 
the guidelines established in the Directorate General for 
Health and Consumer Affairs of the European Commission 
(SANCO) document No. 12495/2011 (Malachová et al., 
2014; SANCO, 2011). Based on this study, Malachová et 
al. (2014) considered that a quantitative determination of 
mycotoxins by LC-MS/MS based on a ‘dilute and shoot’ 
approach is also feasible in case of complex matrices. TDSs 
were developed to estimate the exposure of populations 
to food contaminants, including mycotoxins. From the 
studies presented in Table 2, Sirot et al. (2013) and Sprong 
et al. (2016a) evaluated the exposure of French and Dutch 
populations, respectively, to mycotoxins.. According to 
Lee et al. (2015), countries as Australia, France, Korea and 
China had developed their country-specific TDSs including 
mycotoxins but all countries are encouraged to conduct 
total diet studies to assess the safety and nutritional quality 
of diet of their population since TDS is not only a cost-
effective tool but also a realistic tool for risk assessment of 
chemicals in foods. Actually, the TDS EXPOSURE project 
aims to provide guidance for future TDSs, as well as for 
new TDSs in countries that have no TDS experience (http://
tds-exposure.eu/). Despite the mentioned advantages, TDS 
also present some limitations (e.g. lack of harmonisation 
on how to build up the list of foods or food categories) and 
other type of sampling procedures for food could be applied 
(e.g. duplicate portion). The substitution methods most 
used for the handling of non-detects are the replacement 
of non-detects by LOD values, half LOD values or 0 (EFSA, 
2010). Although, some authors decided also to include the 
LOQ in the management of non-detects (García-Moraleja 
et al., 2015; Sirot et al., 2013). Until now, the assessment 
of mycotoxin exposure is mainly based on deterministic 
approaches, however, there are an increasing number of 
studies applying probabilistic models in last years, as shown 
in Table 2 (Assunção et al., 2015; Cano-Sancho et al., 2013; 
De Boevre et al., 2013; Han et al., 2014; Signorini et al., 
2012; Van de Perre et al., 2015).
Main challenges in exposure assessment to multiple 
mycotoxins
It is quite challenging to estimate the usual food 
consumption considering the limited amount of information 
from national surveys, since not all age groups (infant, 
toddlers, young children or older children, adolescents or 
adults) are included in each national dietary survey. Usually, 
they are conducted on a limited number of days (up to 
seven) and use different methodologies (24h dietary recall, 
food diary, food frequency questionnaire), as summarised 
in Table 2. This lack of harmonisation compromises an 
accurate mycotoxin exposure assessment and does not allow 
the generation of European estimates of dietary exposure. 
To overcome this limitation a recent study was executed to 
assess how existing consumption data could be improved 
by developing a ‘Compiled European Food Consumption 
Database’ (Vilone et al., 2014). According to this study, this 
database provides a fundamental tool to perform exposure 
assessments at the European level.
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Recent surveys highlight the fact that humans are more 
frequently exposed to multiple than to single mycotoxins. 
LC-MS/MS has been the method mostly used for analysis 
and quantification of multiple mycotoxins and their 
metabolites in food (Berthiller et al., 2016; Malachová et 
al., 2014; Turner et al., 2015). As mycotoxins comprise 
a wide range of chemical properties, the extraction and 
chromatographic conditions have to be compromised 
(Capriotti et al., 2012). The influence of matrix effects 
is the major challenge in developing reliable quantitative 
multi-analyte methods therefore, considerable efforts to 
control matrix effects should be carried out to obtain 
accurate results (Turner et al., 2015), namely, the inclusion 
of a sample clean-up step (e.g. using QuEChERS) and the 
compensation of the signal suppression/enhancement 
through the usage of matrix matched standards (Berthiller 
et al., 2016; Malachová et al., 2014; Turner et al., 2015).
Mycotoxin contamination datasets are characterised by the 
presence of non-detects or none quantified values which 
constitutes an important issue for the exposure assessment 
studies (Assunção et al., 2015; Cano-Sancho et al., 2013; 
Sirot et al., 2013). Therefore, a representative food sampling 
design (selecting the most susceptible foods, considering 
a large set of individual and/or composite samples), an 
accurate chemical analysis method (with low detection 
limits) and a suitable method to manage left-censored data 
will be decisive to obtain realistic exposure estimations 
with low level of uncertainty. This could be particularly 
important for the exposure assessment of vulnerable 
population groups such as small children that are generally 
exposed to higher levels of mycotoxins than adults (Alvito 
et al., 2010; Assunção et al., 2015; Cano-Sancho et al., 2013; 
Sirot et al., 2013).
In order to draw more sophisticated exposure scenarios 
an increasing number of authors applied information 
technology on probabilistic models instead of deterministic 
ones. One of the main drawbacks of the deterministic 
approach is that it does not allow calculating complicated 
statistics such as high quartiles. Defining high-level 
consumers is crucial for the outcome of risk assessment. 
In practice, it determines the proportion of the population 
that would exceed a health-based limit. Therefore, when 
refinements are required, simulation methods are proposed 
as the best approach, particularly for high quartiles (Marin 
et al., 2013).
The indirect approach obtained with the combination 
of data of mycotoxin occurrence in food and food 
consumption patterns is associated with some limitations 
for the mycotoxins exposure assessment, including the 
heterogeneous distribution of mycotoxins in food, the 
possible exposure through other exposure routes than 
ingestion, the presence of masked mycotoxins, the influence 
of food processing, inter-individual variation in absorption, 
distribution, metabolism and excretion (ADME), and the 
under- and overestimation in food consumption data 
(Arcella and Leclercq, 2004; Heyndrickx et al., 2014). These 
limitations could lead to an under- and/or overestimation 
of the exposure, and biomarkers have been proposed as a 
suitable alternative. Human biomonitoring is considered a 
quite new frontier for establishing the real human exposure 
to mycotoxins. Recent results on this domain (Gerding et al., 
2014, 2015; Heyndrickx et al., 2015; Warth et al., 2012a,b) 
surprisingly revealed a level of exposure to mycotoxins 
above the widely accepted tolerable daily intake values, 
especially to DON, highlighting the importance to perform 
mycotoxin biomonitoring studies. Typical biomarkers of 
exposure are the parent toxins themselves, protein or DNA 
adducts, and/or major phase I or phase II metabolites (e.g. 
glucuronide conjugates), which are measured in biological 
fluids such as urine or plasma/serum, and are related 
to the actual intake of the toxin through contaminated 
food (Warth et al., 2013). Table 3 summarises studies 
developed in different countries and performed using 
a multibiomarker approach to determine the human 
mycotoxin exposure. LC/MS-MS methods were the mainly 
used for the quantification of biomarkers contents in urine, 
the biological fluid mostly used to determined mycotoxin 
biomarkers contents (Table 3). The number of analytes 
studied simultaneously varied between four (Warth et al., 
2012a) and 33 (Heyndrickx et al., 2015) compounds. The 
use of β-glucuronidase-assisted hydrolysis (in order to 
increase the levels of the parent toxins) (Ahn et al., 2010; 
Shephard et al., 2013; Solfrizzo et al., 2011, 2014; Wallin 
et al., 2015), immunoaffinity columns (IAC) (Ahn et al., 
2010; Rubert et al., 2011; Shephard et al., 2013; Solfrizzo 
et al., 2011, 2014; Wallin et al., 2015) and solid-phase 
extraction (SPE) (Heyndrickx et al., 2015; Njumbe Ediage 
et al., 2012; Rodríguez-Carrasco et al., 2014a,b; Shephard 
et al., 2013; Solfrizzo et al., 2011, 2014; Wallin et al., 2015) 
were applied by some authors as sample preparation and 
clean-up procedures. However, some studies have also 
successfully used the so-called dilute and shoot approach by 
omitting any cleanup procedure (Abia et al., 2013; Ezekiel et 
al., 2014; Gerding et al., 2014, 2015; Heyndrickx et al., 2015; 
Shephard et al., 2013; Warth et al., 2012a,b). Although the 
analysis of mycotoxins in human urine is another important 
data source for exposure assessment, some challenges are 
posed to human mycotoxin multibiomarker approaches. 
These challenges include the lack of toxicokinetic data on 
mycotoxins in humans resulting in a lot of uncertainties 
that should be taken into account when perform a risk 
assessment based on urinary mycotoxin levels; difficulties 
to correlate human dietary habits, concurrent mycotoxin 
contamination of food and consequent presence of these 
mycotoxins in human urine; obstacles to comparison of 
obtained results between different studies, considering 
the differences in age, detection limits, number of subjects 
included in the study and the analytical performances of 
the used methods (Gerding et al., 2014; Heyndrickx et 
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Table 3. Human mycotoxin exposure assessment using a multibiomarker approach.1
Country No. of 
analytes
Analytes included2 Sample preparation and 
cleanup3
Reference
Austria 4 DON, DON-3-GlcA, DON-15-GlcA, DOM-1 ‘dilute and shoot’ Warth et al., 2012a
Bangladesh 23 DON, DON-3-GlcA, T-2, HT-2, HT-2-4-GlcA, FB1, FB2, AFB1, 
AFG2, AFB2, AFM1, ZEA, ZAN, α-ZAL, β-ZAL, ZEA-14-GlcA, 
ZAN-14-GlcA, α/β-ZAL-14-GlcA, OTA, Otα, enniatin B and 
DH-CIT
‘dilute and shoot’ Gerding et al., 2015
Belgium 18 AFM1, AFB1, AFB1-N7-Gua, OTA, OTα, 4-OH-OTA, FB1, HFB1, 
DON, DON-3-GlcA, DOM-1, T-2, HT-2, ZEA, ZEA-14-GlcA, 
α-ZAL, β-ZAL, CIT
liquid-liquid extraction + 
SPE
Njumbe Ediage et al., 2012
33 AFB1, AFB2, AFG1, AFG2, AFM1, FB1, FB2, FB3, HFB1, OTA, 
Otα, T-2, HT-2, DON, DON-3-GlcA, DON-15-GlcA, DOM-1, 
DOM-GlcA, 3-ADON, 3ADON-15-GlcA, 15-ADON, 15ADON-3-
GlcA, DAS, FUS-X, ZEA, ZEA-14-GlcA, α-ZAL, α-ZAL-7-GlcA, 
α-ZAL-14-GlcA, β-ZAL, β-ZAL-14-GlcA, CIT, DH-CIT
‘dilute and shoot’ or liquid-
liquid extraction + SPE
Heyndrickx et al., 2015
Cameroon 15 AFM1, OTA, FB1, FB2, DON, DON-3-GlcA, DON-15-GlcA, DOM-
1, T-2, HT-2, NIV, ZEA, ZEA-14-GlcA, α-ZAL, β-ZAL
‘dilute and shoot’ Abia et al., 2013; Warth et 
al., 2012b
Germany 23 DON, DON-3-GlcA, T-2, HT-2, HT-2-4-GlcA, FB1, FB2, AFB1, 
AFG2, AFB2, AFM1, ZEA, ZAN, α-ZAL, β-ZAL, ZEA-14-GlcA, 
ZAN-14-GlcA, α/β-ZAL-14-GlcA, OTA, Otα, enniatin B and 
DH-CIT
‘dilute and shoot’ Gerding et al., 2014, 2015
Haiti 23 DON, DON-3-GlcA, T-2, HT-2, HT-2-4-GlcA, FB1, FB2, AFB1, 
AFG2, AFB2, AFM1, ZEA, ZAN, α-ZAL, β-ZAL, ZEA-14-GlcA, 
ZAN-14-GlcA, α/β-ZAL-14-GlcA, OTA, Otα, enniatin B and 
DH-CIT
‘dilute and shoot’ Gerding et al., 2015
Italy 7 AFM1, OTA, FB1, DON, DOM-1, α-ZOL, β-ZOL IAC + SPE + 
β-glucuronidase/sulphatase
Solfrizzo et al., 2011
8 DOM-1, DON, AFM1, FB1, β-ZAL, α-ZAL, ZEA, OTA IAC + SPE + 
β-glucuronidase/sulphatase
Solfrizzo et al., 2014
Korea 4 AFM1, OTA, FB1, FB2 IAC + SIDA + 
β-glucuronidase
Ahn et al., 2010
Nigeria 14 AFM1, FB1, FB2, OTA, DON, DON-3-GlcA, DOM-1, NIV, T-2, 
HT-2, ZEA, ZEA-14-GlcA, α-ZAL, β-ZAL
‘dilute and shoot’ Ezekiel et al., 2014
South Africa 15 AFM1, OTA, FB1, FB2, DON, DON-3-GlcA, DON-15-GlcA, DOM-
1, T-2, HT-2, NIV, ZEA, ZEA-14-GlcA, α-ZAL, β-ZAL
‘dilute and shoot’ or IAC + 
β-glucuronidase/sulphatase 
or SPE
Shephard et al., 2013
Spain 11 AFB1, AFB2, AFG1, AFG2, OTA, FB1, FB2, DON, T-2, HT-2, ZEA IAC Rubert et al., 2011
15 DOM-1, DON, 3-ADON, FUS-X, DAS, NIV, NEO, HT-2, T-2, 
ZAN, α-ZAL, β-ZAL, ZEA, α-ZOL, β-ZOL
liquid-liquid extraction + 
SPE
Rodríguez-Carrasco et al., 
2014a,b
Sweden 10 AFM1, DON, FB1, FB2, NIV, OTA, ZEA, α-ZOL, β-ZOL, DOM-1 IAC + SPE + 
β-glucuronidase/sulphatase
Wallin et al., 2015
1 All studies used urine as biological sample. Liquid chromatography coupled with tandem mass spectrometry was used for analysis in all studies, except for Spain 
where gas chromatography coupled with tandem mass spectrometry was used.
2 15-ADON = 15-acetyldeoxynivalenol; 15ADON-3-GlcA = 15-acetyldeoxynivalenol-3-glucuronide; 3-ADON = 3-acetyldeoxynivalenol; 3ADON-15-GlcA = 
3-acetyldeoxynivalenol-15-glucuronide; 4-OH-OTA = hydroxylated form ochratoxin A; AFB1 = aflatoxin B1; AFB1-N7-Gua = aflatoxin B1-N7Guanine; AFB2 = 
aflatoxin B2; AFG1 = aflatoxin G1; AFG2 = aflatoxin G2; AFM1 = aflatoxin M1; α-ZAL = α-zearalanol; α-ZAL-14-GlcA = α-zearalanol-14-glucuronide; α-ZAL-7-GlcA = 
α-zearalanol-7-glucuronide; α-ZOL = α-zearalenol; β-ZAL = β-zearalanol; β-ZAL-14-GlcA = β-zearalanol-14-glucuronide; β-ZOL = β-zearalenol; CIT = citrinin; DAS 
= diacetoxyscirpenol; DH-CIT = dihydrocitrinone; DOM-1 = de-epoxy deoxynivalenol; DOM-GlcA = deepoxy-deoxynivalenol-glucuronide; DON = deoxynivalenol; 
DON-15-GlcA = deoxynivalenol-15-glucuronide; DON-3-GlcA = deoxynivalenol-3-glucuronide; FB1 = fumonisin B1; FB2 = fumonisin B2; FB3 = fumonisin B3; FUS-X = 
fusarenone X; HFB1 = hydrolysed fumonisin B1; HT-2 = HT-2-toxin; HT-2-4-GlcA = HT-2-toxin-4-glucuronide; NIV = nivalenol; OTA = ochratoxin A; OTα = ochratoxin 
alpha; T-2 = T-2-toxin; ZAN = zearalanone; ZAN-14-GlcA = zearalanone-14-glucuronide; ZEA = zearalenone; ZEA-14-GlcA = zearalenone-14-glucuronide.
3 IAC = immunoaffinity column; SIDA = stable isotope dilution assays; SPE = solid phase extraction.
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al., 2015; Rubert et al., 2011; Wallin et al., 2015; Warth et 
al., 2013). For more detailed information on mycotoxin 
multibiomarker approach, see De Nijs et al. (2016).
4. Risk characterisation of multiple mycotoxins
Different approaches for risk characterisation of toxic 
compounds
Risk characterisation is the last step of the risk assessment 
process, integrating information obtained in hazard 
assessment and exposure assessment steps. Risk 
characterisation aims to produce scientific advice for risk 
managers and has been defined as the qualitative and/or 
quantitative estimation, including attendant uncertainties, 
of the probability of occurrence and severity of known 
or potential adverse health effects in a given population 
based on hazard identification, hazard characterisation and 
exposure assessment (FAO/WHO, 2009). Within the risk 
characterisation step, a comparison between the dietary 
exposure and the relevant health-based guidance value is 
performed. It should be highlighted that reference doses 
are only defined for the adult population and this renders 
difficulty in the children and infants risk assessment for 
which the available reference doses are not suitable.
Different approaches have been used for risk characterisation 
of toxic compounds, according to their genotoxic and 
carcinogenic potential. In the risk characterisation for 
non-genotoxic and carcinogenic substances, a health-
based guidance value is compared with estimates of 
dietary exposure. The Hazard Quotient (HQ) is derived 
by comparing their respective reference dose (e.g. tolerable 
daily intake (TDI)) with the exposure to evaluate whether 
the exposure level is tolerable or not, and a ratio of HQ<1 
indicates a tolerable exposure level and a ratio of HQ>1 
indicates a non-tolerable exposure level (EFSA, 2013). 
For those substances that are genotoxic and carcinogenic, 
the traditional assumption is that some degree of risk may 
exist at any level of exposure and it is recommended that 
the exposure should be as low as reasonably achievable 
(ALARA). However, this approach presents limited value, 
because it does not allow risk managers to prioritise 
different contaminants or to target risk management 
actions. The Margin of Exposure (MOE) approach, which 
is the ratio between an amount of a substance producing 
a small but measurable effect in laboratory animals or 
humans and the estimated human exposure, has been 
proposed by WHO and EFSA as the methodology for risk 
characterisation of compounds that are genotoxic and 
carcinogenic (EFSA, 2013; FAO/WHO, 2009). The Scientific 
Committee of EFSA considers that MOE values of 10,000 or 
more, when based on a benchmark dose lower confidence 
limit 10 (BMDL10) from an animal study and taking into 
account overall uncertainties in the interpretation are 
considered ‘of low concern from a public health point of 
view’. Benchmark dose lower confidence limit corresponds 
to the lower boundary of the confidence interval on the 
benchmark dose. EFSA’s Scientific Committee notes that 
the magnitude of a MOE only indicates a level of concern 
and does not quantify risk (EFSA, 2012, 2013).
Given the number of chemicals to which humans are 
potentially exposed, the risk characterisation to this 
exposure should be also addressed. As referred in the 
hazard assessment section, combination effects could 
occur as a result of different chemicals present in food 
and consequently different combined effects could 
happen. Diverse approaches have been used for multiple 
chemicals risk characterisation, most of these are 
based on the concepts of CA and IA. Examples of risk 
characterisation methods include the Hazard Index (HI), 
Point of Departure Index (PODI), Combined Margin of 
Exposure Index (MOET), Toxic Unit Summation (TUS) 
and Relative Potency Factors/Toxic Equivalency Factors 
(RPF/TEF) (Sarigiannis and Hansen, 2012; WHO, 2009). 
The Hazard Index, the mostly used for non-genotoxic 
and carcinogenic compounds, is defined as the sum of the 
respective Hazard Quotients (HQs) for individual mixture 
components, calculated as the ratio between exposure and 
a reference dose and has been put forward as the preferred 
approach when extensive mechanistic information of the 
mixture components is not available. The HI does not 
predict the overall health effect of the mixture, but provide 
a measure of the total risk based on the individual risk 
of each component. Thus, the HI can be used also for 
identification of the largest contributors to the risk (EFSA, 
2013; Sarigiannis and Hansen, 2012). The combined MOE is 
called the MOET, and is calculated as the reciprocal of the 
sum of the reciprocals of the individual MOEs (EFSA PPR, 
2008). MOET is usually used for the mixtures of chemicals 
that have genotoxic and carcinogenic potential. According 
to the PPR Panel of EFSA, no established criteria has been 
set yet to define the magnitude of an acceptable MOE for 
mixtures of chemicals with a threshold effect. However, it 
is widely accepted that for MOEs above the uncertainty 
factor of 100, the combined risk is considered acceptable 
(EFSA PPR, 2008; Sarigiannis and Hansen, 2012).
Characterisation of risk from exposure to multiple 
mycotoxins in food
Several studies were performed to evaluate the dietary 
exposure to mycotoxins (Table 2), although the 
characterisation of risk resulting from that exposure it 
is not usually done. In the last years, few works were 
published applying methodologies of evaluation of risk 
using approaches that consider the simultaneous exposure 
to different mycotoxins. Assunção et al. (2015) performed 
a risk assessment of single and 12 mycotoxins present in 
breakfast cereals consumed by children (1-3 years old) from 
Lisbon region (Portugal). The daily exposure of children 
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to AFs, OTA, FBs and trichothecenes were determined 
using deterministic and probabilistic approaches. For 
the non-carcinogenic mycotoxins, the authors used the 
HI to characterise the risk of mycotoxins from the same 
family group. For the AFs, as carcinogenic compounds, 
MOET was determined to characterise the risk. García-
Moraleja et al. (2015) studied the presence of 21 mycotoxins 
in coffee and calculated the daily intake of mycotoxins 
from coffee consumption using deterministic approach 
at various scenarios of food consumption in Spanish 
adolescents and adults. The risk was characterised via 
comparison with the TDI or the provisional tolerable 
weekly intake (PTWI) proposed by The Joint FAO/WHO 
Expert Committee on Food Additives (JECFA). Han and 
collaborators (2014) assessed the cumulative health risks 
of concomitant exposure via dietary intake to multiple 
mycotoxins, namely DON and its acetyl derivatives of 
3-acetyldeoxynivalenol and 15-acetyldeoxynivalenol. Sirot 
et al. (2013) evaluated the exposure to 25 mycotoxins of 
the general French population within the second French 
total diet study. The health risk assessment was performed 
via comparison of the dietary exposure with international 
health-based guidance values (TDI, PMTDI, or PTWI), and 
the population rate exceeding the health-based guidance 
value was also estimated for adults and children. Cano-
Sancho et al. (2013) assessed the exposure of Catalonian 
(Spain) population to aflatoxins (AFB1, AFB2, AGB1 
and AFG2) and individual AF risk characterisation was 
calculated by estimating the MoEs, dividing the BMDL10 
by the average and percentile 95 of the exposure estimates. 
De Boevre et al. (2013) assessed the quantitative dietary 
exposure of mycotoxins and their modified or masked 
forms (13 in total) through consumption of cereal-based 
food products of the Belgian population. The output of 
exposure (individual and family groups) was compared to 
the mycotoxins TDI.
Main challenges in risk characterisation of multiple 
mycotoxins
As referred previously, humans are naturally and frequently 
exposed to a multitude of mycotoxins, but health 
risk assessments are usually performed on individual 
mycotoxins, which may underestimate the total risks. 
This could be explained by the fact that evaluation of all 
possible combinations of mycotoxins that can occur in food 
and consequently their potential combined toxic effects 
are virtually impossible (FAO/WHO, 2009). One of the 
main challenges posed to risk characterisation of multiple 
mycotoxins is the absence of toxicological data that could be 
used to characterise the risk. The use of toxicological data 
is mandatory to risk characterisation, and independently 
of the mechanisms of combined effects or interactions, 
data of multiple mycotoxins are not yet complete for all 
the toxins potential present in food.
The use of harmonised terminology is an important step for 
a common understanding of the key terms and concepts that 
are used when dealing with combined exposure to multiple 
chemicals for risk assessment purposes (EFSA, 2013). This 
fact constitutes another challenge for risk characterisation 
of multiple mycotoxins in food. It is visible that researchers 
used similar approaches, however not always using the 
same terminology. An improvement in the quality of the 
obtained results is expected if a harmonised approach and 
methodology for risk characterisation is achieved.
5. Conclusions and future perspectives
In the context of food safety, risk assessment is a conceptual 
framework that aims to estimate the risk of occurrence 
of adverse health effects after exposure to mycotoxins 
present in food. Risk assessment of multiple mycotoxins 
is a very challenging domain integrating knowledge from 
different scientific areas and demanding a big effort from 
scientific community, risk assessors and managers. The 
challenges posed to risk assessment of multiple mycotoxins 
were reviewed in the present work, and Figure 1 reflects 
the interrelation between different risk assessment steps 
including the identified challenges for each step.
This study gathers, for the first time, an overview of the main 
challenges associated to the human health risk assessment 
of multiple mycotoxins present in food. Additionally, a 
physiologically-based framework for the hazard assessment 
of multiple mycotoxins in food is proposed. Hazard 
assessment pointed challenges related to the prioritisation 
of mixtures for risk assessment purposes; harmonisation 
of the experimental approaches for toxicity testing and 
mathematical models to analyse interactions, among others. 
Future in vitro and in vivo studies on combinatory toxicology 
are still needed and should be directed to cover: (1) mixtures 
of mycotoxins that are more likely to occur; (2) realistic low 
concentrations, considering the range of human exposure 
measured, e.g. in biomonitoring studies; (3) prolonged 
exposure times to better mimic long-term human exposure 
and (4) several relevant endpoints, including genotoxicity 
and immunotoxicity using high throughput methodologies. 
Furthermore, modelling of data generated in such studies 
using adequate mathematical models is central to uncover 
interactions. On the other hand, exploring genotoxic 
effects and interactions at the mechanistic level remains a 
challenging issue because information on the mechanism 
of action of single mycotoxins within a mixture may be 
somewhat limited, making it difficult to understand their 
interactions. Such data can be generated from toxicity 
studies using predictive and high throughput methodologies, 
including toxicogenomic approaches. Exposure assessment 
highlights the importance concerning the availability of 
harmonised food consumption data to perform exposure 
assessments as well as the development of multianalyte 
methods for multiple mycotoxins quantification in different 
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food matrices. The management of left-censored data is 
crucial for the quantification of low levels of mycotoxins 
as well as the use of probabilistic methods allowing a more 
realistic risk assessment and considering different exposure 
scenarios. Considering that risk characterisation is the 
last step of the risk assessment process, the quality of data 
obtained in the hazard characterisation and exposure 
assessment steps are crucial to evaluate properly the risk 
associated to the exposure to multiple mycotoxins. At this 
level, the availability of toxicological data and the use of 
harmonised terminology pose the main challenges for an 
accurate risk characterisation.
A multidisciplinary effort should be developed to perform 
the human health risk assessment of multiple mycotoxins 
present in food, considering that the information obtained 
from the risk assessment process will be used by risk 
managers to prioritise risk and to develop actions towards 
disease prevention. The present work reinforces the urgent 
need to perform more research studies to clarify the nature 
of interactions among mycotoxins and derive new health-
based guidance values for grouped mycotoxins and/or 
co-occurring mycotoxins in order to protect human health.
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